Bristol Myers (BMY) EVP Cristian Massacesi Sells 6,249 Shares

What Happened

• Cristian Massacesi, EVP, Chief Medical Officer and Head of Development at Bristol Myers Squibb (BMY), sold 6,249 shares in an open-market transaction on September 9, 2026.
• The shares were sold at $64.57 each, generating proceeds of approximately $403,498. This was a sale (not a purchase or option exercise) and is typically considered a routine insider disposition; the filing does not indicate the insider’s motivation.

Key Details

• Transaction date and price: 2026-09-09 — 6,249 shares sold at $64.57 per share.
• Total proceeds: ~ $403,498.
• Shares owned after transaction: Not specified in the provided filing summary.
• Plan/footnotes: No 10b5-1 plan, tax-withholding, or other special footnotes were indicated in the supplied transaction details.
• Filing timeliness: Report filed 2026-09-10 for a 2026-09-09 transaction (filed the next day; no late filing indicated in provided data).

Context

• This was an open-market sale by a company executive. Sales by insiders can be for many reasons (diversification, taxes, personal needs) and, by themselves, do not necessarily signal a change in company prospects.
• No derivative exercise, gift, or award was reported in this transaction. If you track insider activity, compare this sale with other recent insider trades and company fundamentals for broader context.